Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avene Xeracalm balm is a topical lipid-replenishing and moisturizing balm formulated to nourish, soothe, and calm very dry skin prone to atopic dermatitis (eczema), irritation, redness, and itching. It is suitable for all ages including newborns. The product contains key ingredients such as Avène Thermal Spring Water (soothing), I-Modulia complex (reduces itching and inflammation), Cer-Omega lipids (restore the skin barrier), mineral oil (emollient), glycerin (humectant), evening primrose oil (anti-inflammatory/emollient), vitamin E/tocopherol (antioxidant/soothing) and other emollients. The mechanism of action is primarily physical—restoring the skin barrier function by replenishing lipids and reducing transepidermal water loss while providing anti-inflammatory effects through specific actives like I-Modulia. It does not contain fragrances or preservatives due to its sterile packaging process[2][3][4][5][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Avene Xeracalm balm.